Literature DB >> 1850742

Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthase kinase 3).

R J Guan1, B S Khatra, J A Cohlberg.   

Abstract

A highly purified preparation of protein kinase FA (where FA is the activating factor for phosphatase 1)/glycogen synthase kinase 3 from rabbit muscle readily phosphorylated bovine neurofilaments. All three neurofilament proteins, the high, middle, and low molecular proteins (NF-H, NF-M, and NF-L), were phosphorylated when intact filaments were incubated with the kinase. Experiments with individual proteins showed that NF-M was the best substrate. At protein concentrations of 0.13 mg/ml, the initial rate of NF-M phosphorylation was 30% of that observed for glycogen synthase. Km values were 0.24 mg/ml (7 x 10(-7) M tetramer) for glycogen synthase and 0.10 mg/ml (5 x 10(-7) M dimer) for NF-M. Vmax values were 0.36 mumol/min/mg for glycogen synthase and 0.035 mumol/min/mg for NF-M. Dephosphorylated NF-M was phosphorylated only half as much as native NF-M; this is consistent with the known substrate specificity of the kinase. The possible involvement of FA/GSK-3 in the phosphorylation of neurofilaments in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850742

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Identification of the ATP.Mg-dependent protein phosphatase activator (FA) as a synapsin I kinase that inhibits cross-linking of synapsin I with brain microtubules.

Authors:  S D Yang; J S Song; Y T Hsieh; H W Liu; W H Chan
Journal:  J Protein Chem       Date:  1992-10

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 3.  Implications of intermediate filament protein phosphorylation.

Authors:  N O Ku; J Liao; C F Chou; M B Omary
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M.

Authors:  N D Amin; N G Ahn; H Jaffe; C A Winters; P Grant; H C Pant
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

5.  Immunological and biochemical study on tissue and subcellular distributions of protein kinase FA (an activating factor of ATP.Mg-dependent protein phosphatase): a simplified and efficient procedure for high quantity purification from brain.

Authors:  J S Yu; S D Yang
Journal:  J Protein Chem       Date:  1993-12

6.  Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes.

Authors:  W G McLean; C Pekiner; N A Cullum; I F Casson
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

7.  Cyclic modulation of cross-linking interactions of microtubule-associated protein-2 with actin and microtubules by protein kinase FA.

Authors:  S D Yang; J S Song; H W Liu; W H Chan
Journal:  J Protein Chem       Date:  1993-08

8.  Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease.

Authors:  Camila Teixeira Mendes; Fábio Borges Mury; Eloísa de Sá Moreira; Fernando Lopes Alberto; Orestes Vicente Forlenza; Emmanuel Dias-Neto; Wagner Farid Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-10-17       Impact factor: 5.270

Review 9.  KESTREL: a powerful method for identifying the physiological substrates of protein kinases.

Authors:  Philip Cohen; Axel Knebel
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

10.  Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Authors:  Oksana Kaidanovich-Beilin; Tatiana V Lipina; Keizo Takao; Matthijs van Eede; Satoko Hattori; Christine Laliberté; Mustafa Khan; Kenichi Okamoto; John W Chambers; Paul J Fletcher; Katrina MacAulay; Bradley W Doble; Mark Henkelman; Tsuyoshi Miyakawa; John Roder; James R Woodgett
Journal:  Mol Brain       Date:  2009-11-19       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.